Company page
Samsung Biologics Co., Ltd.
Samsung Biologics Co., Ltd. is a leading biopharmaceutical company based in South Korea, with a market capitalization of approximately 42.76 trillion KRW. The company specializes in contract manufacturing and development services for biopharmaceutical products. As a key player in the biotechnology sector, Samsung Biologics is committed to advancing healthcare solutions through innovative biomanufacturing processes.

- Ticker
- 207940:KRX
- Asset type
- Stock
- Market cap
- $42.76B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW